CG Oncology

Irvine, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

$238.0M raised

Dec 2024

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has CG Oncology raised?

CG Oncology has raised $238.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2024.

Who are CG Oncology's investors?

CG Oncology's investors include RA Capital Management, Janus Henderson Investors, TCG Crossover, Foresite Capital, Decheng Capital.

Where is CG Oncology headquartered?

CG Oncology is headquartered in Irvine, United States.

What does CG Oncology do?

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

What stage is CG Oncology at?

CG Oncology is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 12, 2024.

MLA

"CG Oncology — Funding & Investors." VCBacked, December 12, 2024, https://www.vcbacked.co/company/cg-oncology. Accessed July 2, 2026.

APA

VCBacked. (2024). CG Oncology — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cg-oncology

Wikipedia (cite web)

{{cite web |title=CG Oncology — Funding & Investors |url=https://www.vcbacked.co/company/cg-oncology |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 12, 2024.